The Department of Pathology and Laboratory Medicine (DPLM) at Nationwide Children’s Hospital (NCH) seeks a board certified physician trained in either Hematopathology, Transfusion Medicine or Hematology-Oncology with a strong background and academic interest in hemostasis and thrombosis to serve as Director of the Clinical Hemostasis Laboratory at NCH. The successful candidate will lead the advancement of the laboratory services to support the needs of Comprehensive Centers for Hemophilia & Bleeding Disorders, Hemostasis & Thrombosis, Anticoagulation, and the Adolescent and Young Adult Sickle Cell Clinic at NCH. The successful candidate will be responsible for research and development of new clinical tests, refinement of existing clinical tests, quality assurance, and regulatory oversight of clinical testing. Our goal is to further foster the partnership between DPLM and the Division of Hematology, Oncology, Blood & Marrow Transplant for shared resources that will enhance the integrated clinical and research programs for classical hematology at NCH.
The position will provide assistance to the Department’s active learning curriculum for residents, graduate students, pathology and clinical fellows. Fellowship programs offered within the DPLM are the GME sponsored Pediatric Clinical Pathology Program, the only such program in North America, and the ACGME accredited fellowship program in pediatric pathology. The Department is also in the process of launching an International Scholarship for Pathologists and Laboratorians to spend 3 months at NCH. Fellowships in the Division of Hematology, Oncology, Blood & Marrow Transplant include an ACGME accredited Pediatric Hematology-Oncology program and a GME sponsored, advanced fellowship in Pediatric Hemostasis-Thrombosis. Of note, the Hemophilia Treatment Center at NCH is a recognized International Hemophilia Training Center.
The Abigail Wexner Research Institute at NCH is in the top 10 NIH funded pediatric research institutes in the United States. It is the site of the Center for Clinical & Translational Research in which hematology faculty are engaged in the study of the translational epidemiology of pediatric thrombosis, focusing on the clarification of biomarkers and clinical features linked to thrombosis, especially in pediatric kidney disease. Faculty in the Center for Child Health Equity and Outcomes Research are actively engaged in improved von Willebrand disease diagnostic testing and medication adherence for children with chronic classical hematology conditions. There is active participation in clinical trials for new treatments in hemostasis and thrombosis, including new medications and gene therapy for hemophilia, von Willebrand disease and blood clots. The recently established Blood Disease Research Affinity Group is designed to enhance classical hematology research across at NCH. The Research Institute is also the home to one of the world’s largest pediatric biobanks.
The Department of Pathology accessions over 300 bone marrow specimens, over 250 flow cytometry samples, over 1700 hemoglobin electrophoreses, as well as approximately 500 peripheral bloods smears, platelet aggregations and coagulation screenings annually. The clinical laboratories have a volume of >3 million tests per year and the Institute for Genomic Medicine (IGM) clinical laboratory processes 7,000 specimens a year. The test menu of IGM continues to expand to support the DPLM as well as outside facilities across North America.
Ranked in the top 10 children's hospitals on U.S. News & World Report’s 2022-23 “America’s Best Children’s Hospitals Honor Roll,” Nationwide Children’s Hospital is one of the nation’s largest not-for-profit freestanding pediatric healthcare networks.
Inquiries and nominations are encouraged. Please contact: Kathleen Nicol, MD, Section Chief of Clinical Pathology, Bryce Kerlin, MD, PI, Center for Clinical & Translational Research, and/or Amy Dunn, MD, Director of Hematology
Named to the Top 10 Honor Roll on U.S. News & World Report’s 2021-22 list of “Best Children’s Hospitals,” Nationwide Children’s Hospital is one of America’s largest not-for-profit free-standing pediatric health care systems providing unique expertise in pediatric population health, behavioral health, genomics and health equity as the next frontiers in pediatric medicine, leading to best outcomes for the health of the whole child. Integrated clinical and research programs, as well as prioritizing quality and safety, are part of what allows Nationwide Children’s to advance its unique model of care. Nationwide Children’s has a staff of more than 13,000 that provides state-of-the-art wellness, preventive and rehabilitative care and diagnostic treatment during more than 1.6 million patient visits annually. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s physicians train the next generation of pediatricians and pediatric specialists. The Abigail Wexner Research Institute at Nationwide Children’s Hospital is one of the Top 10 National Institutes of Health-funded free-standing pediatric research facilities. More information is... available at NationwideChildrens.org.
The Research Institute at Nationwide Children’s is ranked in the top 10 nationally in NIH funding to free-standing children’s hospitals. Research programs are organized into 12 multidisciplinary Centers of Emphasis structured to encourage collaboration, facilitate team science and foster creativity.